NO961902D0 - Fremgangsmåte for samtidig identifikasjon av differensielt uttrykte mRNA, samt måling av relative konsentrasjoner - Google Patents

Fremgangsmåte for samtidig identifikasjon av differensielt uttrykte mRNA, samt måling av relative konsentrasjoner

Info

Publication number
NO961902D0
NO961902D0 NO961902A NO961902A NO961902D0 NO 961902 D0 NO961902 D0 NO 961902D0 NO 961902 A NO961902 A NO 961902A NO 961902 A NO961902 A NO 961902A NO 961902 D0 NO961902 D0 NO 961902D0
Authority
NO
Norway
Prior art keywords
cdna
mrna
primers
crna
measurement
Prior art date
Application number
NO961902A
Other languages
English (en)
Other versions
NO961902L (no
Inventor
Mark G Erlander
Gregor J Sutcliffe
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO961902D0 publication Critical patent/NO961902D0/no
Publication of NO961902L publication Critical patent/NO961902L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO961902A 1993-11-12 1996-05-10 Fremgangsmåte for samtidig identifikasjon av differensielt uttrykte mRNA, samt måling av relative konsentrasjoner NO961902L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/152,482 US5459037A (en) 1993-11-12 1993-11-12 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
PCT/US1994/013041 WO1995013369A1 (en) 1993-11-12 1994-11-14 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS

Publications (2)

Publication Number Publication Date
NO961902D0 true NO961902D0 (no) 1996-05-10
NO961902L NO961902L (no) 1996-07-12

Family

ID=22543116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961902A NO961902L (no) 1993-11-12 1996-05-10 Fremgangsmåte for samtidig identifikasjon av differensielt uttrykte mRNA, samt måling av relative konsentrasjoner

Country Status (9)

Country Link
US (6) US5459037A (no)
EP (1) EP0726946B1 (no)
JP (1) JPH09509306A (no)
AT (1) ATE251220T1 (no)
CA (1) CA2174966A1 (no)
DE (1) DE69433210D1 (no)
FI (1) FI962000A (no)
NO (1) NO961902L (no)
WO (1) WO1995013369A1 (no)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
RU2111254C1 (ru) * 1994-07-11 1998-05-20 Институт молекулярной биологии им.В.А.Энгельгардта РАН СПОСОБ ДЕТЕКЦИИ ДИФФЕРЕНЦИАЛЬНО ЭКСПРЕССИРУЮЩИХСЯ МАТРИЧНЫХ РНК И КЛОНИРОВАНИЯ СООТВЕТСТВУЮЩИХ ИМ ФРАГМЕНТОВ кДНК
IT1275909B1 (it) * 1995-03-07 1997-10-24 Mirella Pilone Frammento di dna codificante d-amminoacido ossidasi
DE69621507T2 (de) * 1995-03-28 2003-01-09 Japan Science & Tech Corp Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen
US6395887B1 (en) 1995-08-01 2002-05-28 Yale University Analysis of gene expression by display of 3'-end fragments of CDNAS
US5712126A (en) * 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US6418382B2 (en) 1995-10-24 2002-07-09 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5972693A (en) * 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
WO1997029211A1 (en) * 1996-02-09 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services RESTRICTION DISPLAY (RD-PCR) OF DIFFERENTIALLY EXPRESSED mRNAs
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
EP1007730A4 (en) * 1996-08-30 2004-04-28 Invitrogen Corp METHODS OF IDENTIFYING AND ISOLATING SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA
TR199901173T2 (xx) 1996-09-27 1999-07-21 Guilford Pharmaceuticals, Inc. Canl�larda glutamat anormalli�inin tedavisi ve n�ronal aktivitenin d�zenlenmesi i�in y�ntemler ve NAALADase bile�imleri.
WO1998021321A1 (en) * 1996-11-12 1998-05-22 Qbi Enterprises Ltd. Method for identifying translationally regulated genes
US6013437A (en) * 1996-11-12 2000-01-11 Qbi Enterprises, Ltd. Method for identifying translationally regulated genes
WO1998024935A1 (en) * 1996-12-06 1998-06-11 Urocor, Inc. Diagnosis of disease state using mrna profiles
US5968784A (en) * 1997-01-15 1999-10-19 Chugai Pharmaceutical Co., Ltd. Method for analyzing quantitative expression of genes
US6461814B1 (en) 1997-01-15 2002-10-08 Dominic G. Spinella Method of identifying gene transcription patterns
US6306588B1 (en) 1997-02-07 2001-10-23 Invitrogen Corporation Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US5958688A (en) * 1997-04-28 1999-09-28 The Trustees Of The University Of Pennsylvania Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
WO1998049345A1 (en) * 1997-04-29 1998-11-05 Trustees Of Boston University Methods and compositions for targeted dna differential display
US6261770B1 (en) 1997-05-13 2001-07-17 Display Systems Biotech Aps Method to clone mRNAs
JP2001515362A (ja) * 1997-05-13 2001-09-18 ディスプレイ・システムズ・バイオテック・アクティーゼルスカブ ｍＲＮＡをクローニングする方法および差次的に発現された転写物のディスプレイ（ＤＯＤＥＴ）
US6373971B1 (en) * 1997-06-12 2002-04-16 International Business Machines Corporation Method and apparatus for pattern discovery in protein sequences
US6190868B1 (en) 1997-08-07 2001-02-20 Curagen Corporation Method for identifying a nucleic acid sequence
AU1603199A (en) * 1997-12-03 1999-06-16 Curagen Corporation Methods and devices for measuring differential gene expression
US7189833B2 (en) * 1997-12-22 2007-03-13 Serono Genetics Institute S.A. Prostate cancer gene
US6346381B1 (en) 1997-12-22 2002-02-12 Genset Prostate cancer gene
US6265546B1 (en) 1997-12-22 2001-07-24 Genset Prostate cancer gene
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
DE19806431C1 (de) 1998-02-17 1999-10-14 Novartis Ag Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen
JP2002514441A (ja) * 1998-05-11 2002-05-21 クアーク バイオテク インコーポレイテッド 遺伝子の同定方法
DE19822287C2 (de) * 1998-05-18 2003-04-24 Switch Biotech Ag Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
AU6507099A (en) * 1998-09-29 2000-04-17 Arch Development Corporation A new strategy for genome-wide gene analysis: integrated procedures for gene identification
US20020012922A1 (en) * 1998-11-04 2002-01-31 Hilbush Brian S. Simplified method for indexing and determining the relative concentration of expressed messenger RNAs
CA2350168A1 (en) * 1998-11-04 2000-05-11 Digital Gene Technologies, Inc. Method for indexing and determining the relative concentration of expressed messenger rnas
US6194158B1 (en) 1998-11-12 2001-02-27 Nyxis Neurotherapies, Inc. Diagnostic assay for cancer
US6750012B1 (en) * 1998-12-21 2004-06-15 Curagen Corporation Method of identifying a psychotropic agent using differential gene expression
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
AU4342800A (en) * 1999-04-12 2000-11-14 Digital Gene Technologies, Inc. Differential regulation of gene expression in oncogenic transformation
AU4562700A (en) * 1999-05-05 2000-11-21 European Molecular Biology Laboratory Improved predictive power of rna analysis for protein expression
US6334099B1 (en) 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
WO2001032928A2 (en) * 1999-11-05 2001-05-10 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent
WO2001048242A2 (en) 1999-12-29 2001-07-05 Mergen Ltd. Methods for amplifying and detecting multiple polynucleotides on a solid phase support
US20040023231A1 (en) * 2000-04-12 2004-02-05 Abu-Khabar Khalid S. System for identifying and analyzing expression of are-containing genes
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
DK1290444T3 (da) * 2000-06-14 2010-01-18 Vistagen Inc Toxicitetstypisering under anvendelse af lever-stamceller
US7300751B2 (en) * 2000-06-30 2007-11-27 Syngenta Participations Ag Method for identification of genetic markers
EP1356096A2 (en) * 2000-06-30 2003-10-29 Syngenta Participations AG Method for identification, separation and quantitative measurement of nucleic acid fragments
EP1325118B1 (en) 2000-10-05 2016-05-25 Riken Oligonucleotide linkers comprising a variable cohesive portion and method for the preparation of polynucleotide libraries by using said linkers.
US6391592B1 (en) * 2000-12-14 2002-05-21 Affymetrix, Inc. Blocker-aided target amplification of nucleic acids
WO2002059359A2 (en) 2001-01-24 2002-08-01 Syngenta Participations Ag Method for non-redundant library construction
US20030165865A1 (en) * 2001-01-29 2003-09-04 Hinkel Christopher A. Methods of analysis of nucleic acids
DE10114063A1 (de) * 2001-03-22 2002-10-10 Mpb Cologne Gmbh Molecular Pla Neue Pflanzengene und deren Verwendung zur Isolierung von konstitutiven oder induzierbaren Promotoren
EP1372668B1 (en) 2001-03-26 2011-12-07 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US6949340B2 (en) 2001-03-28 2005-09-27 Creative Mines Llc Optical phase modulator
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
AU2002315392B2 (en) 2001-06-22 2008-01-24 Boco Silicon Valley, Inc. Liver engrafting cells, assays, and uses thereof
US20030082584A1 (en) * 2001-06-29 2003-05-01 Liang Shi Enzymatic ligation-based identification of transcript expression
US20030170695A1 (en) * 2001-06-29 2003-09-11 Liang Shi Enzymatic ligation-based identification of nucleotide sequences
US20030170661A1 (en) * 2001-07-23 2003-09-11 Yi Liu Method for identifying a nucleic acid sequence
US20120077196A9 (en) * 2001-09-03 2012-03-29 Guido Krupp Universal method for selective amplification of mRNAs
DE10143106C1 (de) * 2001-09-03 2002-10-10 Artus Ges Fuer Molekularbiolog Vermehrung von Ribonukleinsäuren
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20050026175A1 (en) * 2003-07-31 2005-02-03 John Link Devices and methods for isolating RNA
US20050042660A1 (en) * 2003-07-31 2005-02-24 Hall Gerald Edward Devices and methods for isolating RNA
US20060099605A1 (en) * 2004-11-11 2006-05-11 Hall Gerald E Jr Devices and methods for isolating RNA
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US20080241174A1 (en) * 2005-03-18 2008-10-02 The Board Of Trustees Of The Leland Stanford Junior University Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
US20060270843A1 (en) * 2005-05-26 2006-11-30 Hall Gerald E Jr Methods for isolation of nucleic acids
WO2007028147A2 (en) * 2005-09-01 2007-03-08 Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
WO2008021431A2 (en) 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US8148067B2 (en) 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
EP2190481B1 (en) 2007-07-17 2014-12-24 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
US8669048B2 (en) * 2008-06-24 2014-03-11 Parkinson's Institute Pluripotent cell lines and methods of use thereof
EP2774983B1 (en) * 2011-10-31 2019-05-15 Riken Method for culturing stem cell

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650622B2 (en) * 1989-07-11 1994-06-30 Gen-Probe Incorporated Nucleic acid sequence amplification methods utilizing a transcription complex
JP2726754B2 (ja) * 1991-06-14 1998-03-11 アイシス・ファーマシューティカルス・インコーポレーテッド ｒａｓ遺伝子のアンチセンスオリゴヌクレオチドによる阻害
DE69332665T2 (de) * 1992-03-11 2003-11-27 Dana Farber Cancer Inst Inc Methode um mrna zu klonieren
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US6110680A (en) * 1993-11-12 2000-08-29 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5994068A (en) * 1997-03-11 1999-11-30 Wisconsin Alumni Research Foundation Nucleic acid indexing

Also Published As

Publication number Publication date
EP0726946A4 (en) 1999-02-10
US20020127571A1 (en) 2002-09-12
US5807680A (en) 1998-09-15
FI962000A0 (fi) 1996-05-10
DE69433210D1 (de) 2003-11-06
AU687127B2 (en) 1998-02-19
WO1995013369A1 (en) 1995-05-18
NO961902L (no) 1996-07-12
EP0726946B1 (en) 2003-10-01
JPH09509306A (ja) 1997-09-22
US20030092006A1 (en) 2003-05-15
CA2174966A1 (en) 1995-05-18
US6030784A (en) 2000-02-29
FI962000A (fi) 1996-05-10
ATE251220T1 (de) 2003-10-15
US6309834B1 (en) 2001-10-30
AU1055195A (en) 1995-05-29
US5459037A (en) 1995-10-17
EP0726946A1 (en) 1996-08-21

Similar Documents

Publication Publication Date Title
NO961902D0 (no) Fremgangsmåte for samtidig identifikasjon av differensielt uttrykte mRNA, samt måling av relative konsentrasjoner
MXPA00012757A (es) Metodo mejorado para identificacion simultanea de arnm expresados diferencialmente y medicion de concetraciones relativas.
Jessen et al. Laryngeal features in German
Frost Prelexical and postlexical strategies in reading: evidence from a deep and a shallow orthography.
Luse et al. Abortive initiation by RNA polymerase II in vitro at the adenovirus 2 major late promoter.
Semsei et al. Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain
Weber et al. Key enzymes of IMP metabolism: Transformation-and proliferation-linked alterations in gene expression
Friesen et al. Synthesis and turnover of basal level guanosine tetraphosphate in Escherichia coli.
Shanmugam et al. Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat
CN106434982B (zh) 缺血性脑卒中相关的分子标记物及其应用
ES2018916A6 (es) Un metodo de ensayo de hibridacion de acidos nucleicos.
Zeeberg et al. Incorporation of radioactive tubulin into microtubules at steady state. Experimental and theoretical analyses of diffusional and directional flux.
Holmes et al. Structural requirements for tRNA methylation. Action of Escherichia coli tRNA (guanosine-1) methyltransferase on tRNA (1Leu) structural variants.
Sen et al. Identification of the messenger RNAs coding for the gag and env gene products of the murine mammary tumor virus
EA200100490A1 (ru) Способ индексации и определения относительной концентрации экспрессирующихся информационных рнк
Wurm Classifications of Australian languages, including Tasmanian
Paoletti In vitro synthesis of a high molecular weight virion-associated RNA by vaccinia.
Lea et al. DNA metabolism in liver and kidney tumors of different growth rates
Munns et al. Effects of estradiol on uterine ribonucleic acid metabolism. II. Methylation of ribosomal ribonucleic acid and trannsfer ribonucleic acid
Bhat et al. Changing patterns of renal retinal dehydrogenase expression parallel nephron development in the rat
BR9712368A (pt) Gene clk-1,modelo de camundongo de longevidade e processos para diagnóstico e/ou prognóstico de câncer em um paciente, para aumento do espaço de tempo de vida de um animal ou um paciente, e, para tratamento de condições patológicas que provocam a redução do ritmo da taxa fisiológica de tecido e/ou órgão em um paciente.
Brass et al. Disassociation between acidinsoluble acylcarnitines and ketogenesis following carnitine administration in vivo
Zhouyao et al. The Human Major Facilitator Superfamily Domain Containing 14A (MFSD14A) Gene Does Not Encode a Glucose Transporter
Kan-Mitchell et al. Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
Eichler et al. Effect of human placental ribonuclease inhibitor in cell-free ribosomal RNA synthesis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application